Regulations.gov document
Orange Book_ Approved Drug Products with Therapeutic Equivalence Evaluations-250mg-natco…
Supporting & Related Material · FDA-2018-P-3616 · posted Sep 25, 2018
Key facts
| Document ID | FDA-2018-P-3616-0008 |
|---|---|
| Title | Orange Book_ Approved Drug Products with Therapeutic Equivalence Evaluations-250mg-natco re Citizen Petition from Suven Life Sciences Limited |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2018-P-3616 |
| Posted | Sep 25, 2018 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: